Veralto Corporation filings document the regulatory record for a Delaware operating company focused on essential water and product quality solutions. Form 8-K reports furnish quarterly and annual operating results, non-GAAP measures, cash flow commentary, completed acquisitions, cost optimization actions and other material events.
Its proxy and governance filings cover annual meeting proposals, director elections, executive compensation and shareholder voting matters. Other current reports address capital-structure actions such as common-stock repurchase authorizations, officer transitions, compensatory arrangements and related governance disclosures.
Wallis-Lage Cindy L. reported acquisition or exercise transactions in this Form 4 filing.
Veralto Corp director Cindy L. Wallis-Lage received equity awards. She was granted 1,009 restricted stock units that vest on the earlier of the first anniversary of the grant or the next annual shareholders meeting, with shares issued only after board retirement or death. She also received 3,553 fully vested director stock options to buy common shares at $91.00 per share, expiring in 2036, bringing her holdings to 3,380 common shares and 9,413 options held directly.
Veralto Corp director Vijay P. Sankaran reported equity awards. On 2026-07-15 he received 1009.0000 restricted stock units that vest on the earlier of one year or the next annual shareholder meeting, with share delivery deferred until death or several months after board retirement. He was also granted 3553.0000 director stock options for common stock at an exercise price of $91.0000 per share, expiring on 2036-07-15, bringing his direct holdings to 2669.0000 common shares and 7823.0000 options.
Veralto director Heath A. Mitts received equity awards on 2026-07-15, including 1,009 restricted stock units that vest by the earlier of the first anniversary or the next shareholder meeting, with shares issued upon the earlier of his death or the first date of the seventh month after board retirement. He also received 3,553 fully vested director stock options with a $91.00 exercise price expiring on 2036-07-15, bringing his direct holdings to 3,500 common shares and 9,413 options.
Veralto director Walter G. Lohr received equity compensation on July 15, 2026, including 1,009 restricted stock units and 3,553 director stock options. The RSUs vest on the earlier of one year or the next shareholder meeting, with shares delivered after board service ends, while the options are fully vested, carry a $91 exercise price, and expire in 2036. Following these awards he holds 3,380 common shares and 9,413 options directly.
Veralto Corp director William King received equity awards on 2026-07-15. He acquired 1,009 shares of common stock through a grant of restricted stock units that vest on the earlier of the first anniversary of the grant or the next annual shareholder meeting, with shares issued after he leaves the board.
He also received 3,553 director stock options for common stock at an exercise price of $91.00 per share, fully vested at grant and expiring on 2036-07-15. Following these awards he directly holds 9,557 common shares and 9,413 director stock options.
Veralto Corp director Shyam Kambeyanda received equity compensation consisting of 1,099 restricted stock units tied to common stock and 3,553 director stock options with a $91.00 exercise price.
The RSUs vest on the earlier of the first anniversary of the grant date or immediately before the next annual shareholders’ meeting, while the underlying shares are issued only upon the earlier of the director’s death or seven months after retirement from the Board. The options are fully vested as of the grant date and expire on July 15, 2036. Following these grants, Kambeyanda holds 3,470 common shares and 9,413 stock options.
Veralto director Daniel L. Comas received equity compensation on July 15, 2026, comprising 1,099 restricted stock units and 3,553 director stock options with a $91.00 exercise price. The RSUs vest by the first anniversary or next shareholder meeting with deferred share delivery; the options are fully vested at grant. After these awards he holds 18,509 common shares and 9,413 options, all reported as directly owned.
Veralto Corp director Francoise Colpron reported equity awards dated 2026-07-15. She received 1,099 restricted stock units, which vest at the earlier of one year or the next shareholder meeting, and 3,553 director stock options at a $91.00 exercise price, fully vested at grant. She now holds 3,470 common shares and 9,413 options directly.
Linda Filler, a director of Veralto Corp, received equity compensation on July 15, 2026. She was granted restricted stock units covering 825 and 1,009 shares of common stock, vesting on the earlier of one year from grant or the next annual shareholders meeting, with shares issued only at the earlier of her death or the first date of the seventh month after her retirement from the board. She was also granted director stock options for 2,665 and 3,553 shares at an exercise price of $91 per share, fully vested at grant and expiring on July 15, 2036.
Veralto Corp SVP and Chief Financial Officer Sameer Ralhan had 3,305 shares of Common Stock withheld on 2026-07-15 to satisfy tax obligations, at a value of $91.00 per share. After this tax-withholding disposition, he directly owns 53,694 shares. This transaction is characterized under code F as payment of tax liability by delivering securities.